TIMING AND MAGNITUDE OF INITIAL RESPONSE TO CERTOLIZUMAB PEGOL IN A BROAD POPULATION OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS PREDICTS LIKELIHOOD OF LDA AT WEEK 28